Histotripsy methods in mechanical disintegration of tissue: Towards clinical applications

International Journal of Hyperthermia

Volumn 31, Issue 2, 2015, Pages 145-162

  Khokhlova, Vera A ^a,b   Fowlkes, J Brian ^c,d   Roberts, William W ^d   Schade, George R ^e   Xu, Zhen ^d   Khokhlova, Tatiana D ^e   Hall, Timothy L ^d   Maxwell, Adam D ^a,e   Wang, Yak Nam ^a   Cain, Charles A ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

High intensity focused ultrasound; Physics; Ultrasound

Indexed keywords

ABLATION THERAPY; CANCER IMMUNOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; ECHOGRAPHY; FIBRINOLYTIC THERAPY; HISTOTRIPSY; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LIVER CANCER; MEDICAL TECHNOLOGY; NEPHROLITHIASIS; NONHUMAN; NONSURGICAL INVASIVE THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHYSICAL MEDICINE; PROSTATE DISEASE; PROSTATE HYPERTROPHY; REGENERATIVE MEDICINE; REVIEW; STONE DISSOLUTION; TARGET ORGAN; THROMBOSIS; TISSUE ENGINEERING; TISSUE REGENERATION; TUMOR IMMUNITY; ULTRASOUND THERAPY; DEVICES; HIGH INTENSITY FOCUSED ULTRASOUND; LITHOTRIPSY; NEOPLASMS; PROCEDURES;

HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; LITHOTRIPSY; NEOPLASMS; TISSUE ENGINEERING;

EID: 84928173972     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2015.1007538     Document Type: Review

References (135)

1. Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH. High-intensity focused ultrasound: Current potential and oncologic applications. Am J Roentgenol 2008;190:191-9.
2. Kim YS, Kim JH, Rhim H, Lim HK, Keserci B, Bae DS, et al. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: Initial clinical outcomes. Radiology 2012;263:600-9.
3. Crouzet S, Chapelon JY, Rouvière O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H, et al. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: Oncologic outcomes and morbidity in 1002 patients. Eur Urol 2014;65:907-14.
4. Illing RO, Kennedy JE, Wu F, ter Haar GR, Protheroe AS, Friend PJ, et al. The safety and feasibility of extracorporeal highintensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a western population. Br J Cancer 2005;93: 890-5.
5. Wu F, Wang ZB, Chen WZ, Wang W, Gui Y, Zhang M, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: An overview. Ultrason Sonochem 2004;11:149-54.
6. Napoli A, Anzidei M, Marincola BC, Brachetti G, Ciolina F, Cartocci G, et al. Primary pain palliation and local tumor control in bone metastases treated with magnetic resonance-guided focused ultrasound. Invest Radiol 2013;48:351-8.
7. Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Zadicario E, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2013;369:640-8.
8. Coluccia D, Fandino J, Schwyzer L, O'Gorma R, Remonda R, Martins E, et al. First non-invasive thermal ablation of a brain tumor with MR guided focused ultrasound. J Neurol Surg A Cent Eur Neurosurg 2014;75:50. https://www.thieme-connect.com/ products/ejournals/abstract/10.1055/s-0034-1383780.
9. Hall TL, Fowlkes JB, Cain CA. Imaging feedback of tissue liquefaction (histotripsy) in ultrasound surgery. 2005 IEEE Ultrasonics Symposium. Rotterdam, September 2005.
10. Canney M, Khokhlova V, Hwang JH, Khokhlova T, Bailey M, Crum L. Tissue erosion using shock wave heating and millisecond boiling in high intensity ultrasound field. Proc. 9th Int Symp Therapeut Ultrasound 2009;1:36-9.
11. Bailey MR, Khokhlova VA, Sapozhnikov OA, Kargl SG, Crum LA. Physical mechanisms of the therapeutic effect of ultrasound. Acoust Phys 2003;49:369-88.
12. Parsons JE, Cain CA, Abrams GD, Fowlkes JB. Pulsed cavitational ultrasound therapy for controlled tissue homogenization. Ultrasound Med Biol 2006;32:115-29.
13. Maxwell AD, Cain CA, Hall TL, Fowlkes JB, Xu Z. Probability of cavitation for single ultrasound pulses applied to tissues and tissuemimicking materials. Ultrasound Med Biol 2013;39:449-65.
14. Lin KW, Kim Y, Maxwell A, Wang TY, Hall T, Xu Z, et al. Histotripsy beyond the intrinsic cavitation threshold using very short ultrasound pulses: Microtripsy. IEEE Trans Ultrason Ferroelectr Freq Control 2014;61:251-65.
15. Maxwell AD, Wang TY, Cain CA, Fowlkes JB, Sapozhnikov OA, Bailey MR, et al. Cavitation clouds created by shock scattering from bubbles during histotripsy. J Acoust Soc Am 2011;130: 1888-98.
16. Khokhlova TD, Canney MS, Khokhlova VA, Sapozhnikov OA, Crum LA, Bailey MR. Controlled tissue emulsification produced by high intensity focused ultrasound shock waves and millisecond boiling. J Acoust Soc Am 2011;130:3498-510.
17. Canney MS, Bailey MR, Crum LA, Khokhlova VA, Sapozhnikov OA. Acoustic characterization of high intensity focused ultrasound fields: A combined measurement and modeling approach. J Acoust Soc Am 2008;124:2406-20.
18. Canney MS, Khokhlova VA, Bessonova OV, Bailey MR, Crum LA. Shock-induced heating and millisecond boiling in gels and tissue due to high intensity focused ultrasound. Ultrasound Med Biol 2010;36:250-67.
19. Simon JC, Sapozhnikov OA, Khokhlova VA, Wang YN, Crum LA, Bailey MR. Ultrasonic atomization of tissue and its role in tissue fractionation by high intensity focused ultrasound. Phys Med Biol 2012;57:8061-78.
20. Wang YN, Khokhlova T, Bailey M, Hwang JH, Khokhlova V. Histological and biochemical analysis of mechanical and thermal bioeffects in boiling histotripsy lesions induced by high intensity focused ultrasound. Ultrasound Med Biol 2013;39:424-38.
21. Khokhlova TD, Wang YN, Simon JC, Cunitz BW, Starr F, Paun M, et al. Ultrasound-guided tissue fractionation by high intensity focused ultrasound in an in vivo porcine liver model. Proc Natl Acad Sci USA 2014;111:8161-6.
22. Maxwell A, Sapozhnikov O, Bailey M, Crum L, Xu Z, Fowlkes B, et al. Disintegration of tissue using high intensity focused ultrasound: Two approaches that utilize shock waves. Acoust Today 2012;8(4):24-36.
23. Barry MJ, Fowler Jr FJ, O'LearyMP, Bruskewitz RC, Holtgrewe HL, Menust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia: The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57.
24. Roehrborn CG, McConnell JD. Etiology, pathophysiology, epidemiology, and natural history of BPH. In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ, editors Campbell's Urology. Philadelphia: Saunders, 2002.
25. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132: 474-9.
26. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: Benign prostatic hyperplasia. J Urol 2005;173:1256-61.
27. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of thirteen participating institutions evaluating 3885 patients. J Urol 1989;141:243-7.
28. Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989;320:1120-3.
29. Lake AM, Hall TL, Kieran K, Fowlkes JB, Cain CA, Roberts WW. Histotripsy: Minimally invasive technology for prostate tissue ablation in an in vivo canine model. Urology 2008;72:682-6.
30. Hall TL, Hempel CR, Wojno K, Xu Z, Cain CA, Roberts WW: Histotripsy of the prostate: Dose effects in a chronic canine model. Urology 2009;74:932-7.
31. Schade GR, Hall TL, Roberts WW. Urethral-sparing histotripsy of the prostate in a canine model. Urology 2012;80:730-5.
32. Wheat JC, Hall TL, Hempel CR, Cain CA, Xu Z, Roberts WW. Prostate histotripsy in an anticoagulated model. Urology 2010;75: 207-11.
33. Firth AM, Haldane SL. Development of a scale to evaluate postoperative pain in dogs. J Am Vet Med Assoc 1999;214:651-9.
34. Hempel CR, Hall TL, Cain CA, Fowlkes JB, Xu Z, Roberts WW. Histotripsy fractionation of prostate tissue: Local effects and systemic response in a canine model. J Urol 2011;185:1484-9.
35. Styn N, Hall TL, Fowlkes JB, Cain CA, Roberts WW. Histotripsy homogenization of the prostate: Thresholds for cavitation damage of periprostatic structures. J Endourol 2011;25:1531-5.
36. Allam C, Wilkinson JE, Cheng X, Ives KA, Hall TL, Roberts WW. Histotripsy effects on the bladder trigone: Functional and histologic consequences in the canine model. J Endourol 2013;27: 1267-71.
37. Schade GR, Keller J, Ives K, Cheng X, Rosol TJ, Keller E, et al. Histotripsy focal ablation of implanted prostate tumor in an ACE-1 canine cancer model. J Urol 2012;188:1957-64.
38. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004;127: S5-16.
39. Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, et al. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 2009;15:859-68.
40. Livraghi T, Makisalo H, Line PD. Treatment options in hepatocellular carcinoma today. Scand J Surg 2011;100:22-9.
41. Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis. Surg Oncol 2010;19:e22-32.
42. Gage AA, Baust JG. Cryosurgery for tumors. J Am Coll Surg 2007; 205:342-56.
43. Dick EA, Taylor-Robinson SD, Thomas HC, Gedroyc WM. Ablative therapy for liver tumours. Gut 2002;50:733-9.
44. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: Updated review in 2010. Oncology 2010;78:S113-24.
45. McWilliams JP, Yamamoto S, Raman SS, Loh CT, Lee EW, Liu DM, et al. Percutaneous ablation of hepatocellular carcinoma: Current status. J Vasc Interv Radiol 2010;21(Suppl.8): S204-13.
46. Al-Bataineh O, Jenne J, Huber P. Clinical and future applications of high intensity focused ultrasound in cancer. Cancer Treat Rev 2012; 38(5):346-53.
47. Okada A, Murakami T, Mikami K, Onishi H, Tanigawa N, Marukawa T, et al. A case of hepatocellular carcinoma treated by MR-guided focused ultrasound ablation with respiratory gating. Magn Reson Med Sci 2006;5:167-71.
48. Jung SE, Cho SH, Jang JH, Han JY. High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: Complications. Abdom Imaging 2011;36:185-95.
49. Hall TL, Lee GR, Hernandez L, Cain CA. Relaxation properties of cavitation induced tissue lesions. Poster, Joint Annual Meeting of the International Society for Magnetic Resonance in Medicine, Berlin, Germany, May 2007.
50. Wang TY, Xu Z, Winterroth F, Hall TL, Fowlkes JB, Rothman ED, et al. Quantitative ultrasound backscatter for pulsed cavitational ultrasound therapy-Histotripsy. IEEE Trans Ultrason Ferroelectr Freq Control 2009;56:995-1005.
51. Bobkova S, Gavrilov L, Khokhlova V, Shaw A, Hand J. Focusing of high-intensity ultrasound through the rib cage using a therapeutic random phased array. Ultrasound Med Biol 2010;36: 888-906.
52. Khokhlova VA, Bobkova SM, Gavrilov LR. Focus splitting associated with propagation of focused ultrasound through the rib cage. Acoust Phys 2010;56:665-74.
53. Wang H, Ebbini E, O'Donnell M, Cain CA. Phase abberation correction and motion compensation for ultrasonic phased arrays: Experimental results. IEEE Trans Ultrason Ferroelectr Freq Control 1994;41:34-43.
54. Kim Y, Wang TY, Xu Z, Cain CA. Lesion generation through ribs using histotripsy therapy without aberration correction. IEEE Trans Ultrason Ferroelectr Freq Control 2011;58:2334-43.
55. Kim Y, Vlaisavljevich E, Owens GE, Allen SP, Cain CA, Xu Z. In vivo transcostal histotripsy therapy without aberration correction. Phys Med Biol 2014;59:2553-68.
56. Vlaisavljevich E, Kim Y, Allen S, Owens G, Pelletier S, Cain C, et al. Image-guided non-invasive ultrasound liver ablation using histotripsy: Feasibility study in an in vivo porcine model. Ultrasound Med Biol 2013;39:1398-409.
57. Vlaisavljevich E, Kim Y, Owens G, Roberts W, Cain C, Xu Z. Effects of tissue mechanical properties on susceptibility to histotripsy-induced tissue damage. Phys Med Biol 2014;59:253-70.
58. Bulger C, Jacobs C, Patel N. Epidemiology of acute deep vein thrombosis. Tech Vasc Interv Radiol 2004;7:50-4.
59. Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998;339: 93-104.
60. Rogers LQ, Lutcher CL. Streptokinase therapy for deep vein thrombosis: A comprehensive review of the English literature. Am J Med 1990;88:389-95.
61. Sharafuddin MJ, Sun S, Hoballah JJ, Youness FM, Sharp WJ, Roh BS. Endovascular management of venous thrombotic and occlusive diseases of the lower extremities. J Vasc Interv Radiol 2003;14:405-23.
62. Meunier J, Holland C, Lindsell C, Shaw G. Duty cycle dependence of ultrasound enhanced thrombolysis in a human clot model. Ultrasound Med Biol 2007;33:576-83.
63. Parikh S, Motarjeme A, McNamara T, Raabe R, Hagspiel K, Benenati JF, et al. Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: Initial clinical experience. J vasc interv radiol 2008;19:521-8.
64. Rosenschein U, Furman V, Kerner E, Fabian I, Bernheim J, Eshel Y. Ultrasound imaging-guided noninvasive ultrasound thrombolysis: Preclinical results. Circulation 2000;102:238-45.
65. Wright C, Hynynen K, Goertz D. In vitro and in vivo high-intensity focused ultrasound thrombolysis. Invest Radiol 2012;47:217-25.
66. Deng CX, Xu Q, Apfel RE, Holland CK. In vitro measurements of inertial cavitation thresholds in human blood. Ultrasound Med Biol 1996;22:939-48.
67. Daniels S, Kodama T, Price DJ. Damage to red blood cells induced by acoustic cavitation. Ultrasound Med Biol 1995;21: 113-19.
68. Kieran K, Hall TL, Parsons JE, Wolf Jr JS, Fowlkes JB, Cain CA, et al. Refining histotripsy: Defining the parameter space for the creation of nonthermal lesions with high intensity, pulsed focused ultrasound of the in vitro kidney. J Urol 2007;178:672-6.
69. Xu Z, Fowlkes JB, Ludomirsky A, Cain CA. Investigation of intensity thresholds for ultrasound tissue erosion. Ultrasound Med Biol 2005;31:1673-82.
70. Xu Z, Fan Z, Hall TL, Winterroth F, Fowlkes JB, Cain CA. Size measurement of tissue debris particles generated from pulsed ultrasound cavitational therapy-Histotripsy. Ultrasound Med Biol 2009;35:245-55.
71. Maxwell AD, Cain CA, Duryea AP, Yuan L, Gurm HS, Xu Z. Noninvasive thrombolysis using pulsed ultrasound cavitation therapy-Histotripsy. Ultrasound Med Biol 2009;35:1982-94.
72. Maxwell AD, Owens G, Gurm HS, Ives K, Myers Jr DD, Xu Z. Noninvasive treatment of deep venous thrombosis using pulsed ultrasound cavitation therapy (histotripsy) in a porcine model. J Vasc Interv Radiol 2011;22:369-77.
73. Maxwell AD, Park S, Vaughan BL, Cain CA, Grotberg JB, Xu Z. Trapping of embolic particles in a vessel phantom by cavitationenhanced acoustic streaming. Phys Med Biol 2014;59:4927-43.
74. Park S, Maxwell AD, Owens GE, Gurm HS, Cain CA, Xu Z. Noninvasive embolus trap using histotripsy-An acoustic parameter study. Ultrasound Med Biol 2013;39:611-19.
75. Xu Z, Fowlkes JB, Rothman ED, Levin AM, Cain CA. Controlled ultrasound tissue erosion: The role of dynamic interaction between insonation andmicrobubble activity. JAcoust SocAm2005;117:424-35.
76. Ryan LK, Foster FS. Tissue equivalent vessel phantom for intravascular ultrasound. Ultrasound Med Biol 1997;23:261-73.
77. Scales Jr CD, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol 2012;62:160-5.
78. Mobley TB, Myers DA, Grine WB, Jenkins JM, Jordan WR. Low energy lithotripsy with the Lithostar: Treatment results with 19 962 renal and ureteral calculi. J Urol 1993;149:1419-24.
79. Liston TG, Montgomery BS, Bultitude MI, Tiptaft RC. Extracorporeal shock wave lithotripsy with the Storz Modulith SL20: The first 500 patients. Br J Urol 1992;69:465-9.
80. Coz F, Orvieto M, Bustos M, Lyng R, Stein C, Hinrichs A, et al. Extracorporeal shockwave lithotripsy of 2000 urinary calculi with the modulith SL-20: Success and failure according to size and location of stones. J Endourol 2000;14:239-46.
81. Pishchalnikov YA, Sapozhnikov OA, Bailey MR, Williams Jr JC, Cleveland RO, Colonius T, et al. Cavitation bubble cluster activity in the breakage of kidney stones by lithotripter shockwaves. J Endourol 2003;17:435-46.
82. Duryea AP, Hall TL, Maxwell AD, Xu Z, Cain CA, Roberts WW. Histotripsy erosion of model urinary calculi. J Endourol 2011;25: 341-4.
83. Zhu S, Cocks FH, Preminger GM, Zhong P. The role of stress waves and cavitation in stone comminution in shock wave lithotripsy. Ultrasound Med Biol 2002;28:661-71.
84. Duryea AP, Roberts WW, Cain CA, Tamaddoni HA, Hall TL. Acoustic bubble removal to enhance SWL efficacy at high shock rate: An in vitro study. J Endourol 2014;28:90-5.
85. Duryea AP, Roberts WW, Cain CA, Hall TL. Removal of residual nuclei to enhance histotripsy kidney stone erosion at high rate. J Acoust Soc Am 2014;136:2193.
86. Delius M. Minimal static excess pressure minimises the effect of extracorporeal shock waves on cells and reduces it on gallstones. Ultrasound Med Biol 1997;23:611-17.
87. Zhong P, Zhou Y. Suppression of large intraluminal bubble expansion in shock wave lithotripsy without compromising stone comminution: Methodology and in vitro experiments. J Acoust Soc Am 2001;110:3283-91.
88. Bailey MR, Blackstock DT, Cleveland RO, Crum LA. Comparison of electrohydraulic lithotripters with rigid and pressure-release ellipsoidal reflectors. II. Cavitation fields. J Acoust Soc Am 1999; 106:1149-60.
89. Xi X, Zhong P. Improvement of stone fragmentation during shockwave lithotripsy using a combined EH/PEAA shock-wave generator-In vitro experiments. Ultrasound Med Biol 2000;26:457-67.
90. Wang TY, Xu Z, Hall T, Fowlkes J, RobertsW, Cain C. Active focal zone sharpening for high-precision treatment using histotripsy. IEEE Trans Ultrason Ferroelectr Freq Control 2011;58:305-15.
91. Maxwell AD, Kreider W, Yuldashev PV, Khokhlova TD, Sapozhnikov OA, Bailey MR, et al. A boiling histotripsy system for deep tissue ablation. Conference program and abstracts, 13th International Symposium for Therapeutic Ultrasound, Shanghai, China (ISTU 2013) p. 131.
92. Bessonova OV, Khokhlova VA, Canney MS, Bailey MR, Crum LA. A derating method for therapeutic applications of high intensity focused ultrasound. Acoust Phys 2010;56:376-85.
93. Duck F. Physical properties of tissue: A comprehensive reference book. London: Academic Press, 1990.
94. Yuldashev PV, Shmeleva SM, Ilyin SA, Sapozhnikov OA, Gavrilov LR, Khokhlova VA. The role of acoustic nonlinearity in tissue heating behind a rib cage using high intensity focused ultrasound phased array. Phys Med Biol 2013;58:2537-59.
95. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
96. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: Analysis of the National Cancer Data Base. Cancer 2008;113:78-83.
97. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009;182: 1271-9.
98. Zargar H, Allaf M, Bhayani S, Stifelman M, Rogers C, Ball M, et al. Trifecta and optimal peri-operative outcomes of robotic and laparoscopic partial nephrectomy in surgical treatment of small renal masses: A multi-institutional study. BJU Int 2014. doi: 10.1111/bju.12933.
99. Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013;63:486-92.
100. Marberger M, Schatzl G, Cranston D, Kennedy JE. Extracorporeal ablation of renal tumours with high-intensity focused ultrasound. BJU Int 2005;95(Suppl2):52-5.
101. Ritchie RW, Leslie T, Phillips R, Wu F, Illing R, ter Haar G, et al. Extracorporeal high intensity focused ultrasound for renal tumours: A 3-year follow-up. BJU Int 2010;106:1004-9.
102. Roberts WW, Hall TL, Ives K, Wolf JS, Fowlkes JB, Cain CA. Pulsed cavitational ultrasound: A noninvasive technology for controlled tissue ablation (histotripsy) in the rabbit kidney. J Urol 2006;175:734-8.
103. Hall TL, Kieran K, Ives K, Fowlkes JB, Cain CA, Roberts WW. Histotripsy of rabbit renal tissue in vivo: Temporal histologic trends. J Endourol 2007;21:1159-66.
104. Lake AM, Xu Z, Wilkinson JE, Cain CA, Roberts WW. Renal ablation by histotripsy-Does it spare the collecting system? J Urol 2008;179:1150-54.
105. Styn NR, Wheat JC, Hall TL, Roberts WW. Histotripsy of VX-2 tumor implanted in a renal rabbit model. J Endourol 2010;24: 1145-50.
106. Schade GR, Maxwell AD, Khokhlova TD, Wang YN, Sapozhnikov OA, Bailey MR, et al. Boiling histotripsy of the kidney: Preliminary studies and predictors of treatment effectiveness. J Acoust Soc Am 2014;136:2251.
107. Wu F, Zhou L, Chen WR. Host antitumour immune responses to HIFU ablation. Int J Hyperthermia 2007;23:165-71.
108. Xia JZ, Xie FL, Ran LF, Xie XP, Fan YM, Wu F. High-intensity focused ultrasound tumor ablation activates autologous tumorspecific cytotoxic T lymphocytes. Ultrasound Med Biol 2012;38: 1363-71.
109. Lu P, Zhu XQ, Xu ZL, Zhou Q, Zhang J, Wu F. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer. Surgery 2009;145:286-93.
110. Dromi SA, Walsh MP, Herby S, Traughber B, Xie J, Sharma KV, et al. Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology 2009;251:58-66.
111. Wissniowski TT, Hänsler J, Neureiter D, Frieser M, Schaber S, Esslinger B, et al. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res 2003;63:6496-500.
112. Hu Z, Yang XY, Liu Y, Sankin GN, Pua EC, Morse MA, Lyerly HK, et al. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med 2007;11:5-34.
113. Xing Y, Lu X, Pua EC, Zhong P. The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model. Biochem Biophys Res Commun 2008;375:645-50.
114. Huang X, Yuan F, Liang M, Lo HW, Shinohara ML, Robertson C, et al. M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer. PLoS One 2012;7:e41632.
115. Khokhlova TD, Simon JC, Wang YN, Paun P, Starr FL, Khokhlova VA, et al. In vivo tissue emulsification using millisecond boiling induced by high intensity focused ultrasound. J Acoust Soc Am 2011;129:2477.
116. Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, Vyth-Dreese FA, et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 2003;198:569-80.
117. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 1995;21:243-8.
118. Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol 2004;12:367-77.
119. Grikscheit TC, Vacanti JP. The history and current status of tissue engineering: The future of pediatric surgery. J Pediatr Surg 2002; 37:277-88.
120. Frerich B, Lindemann N, Kurtz-Hoffmann J, Oertel K. In vitro model of a vascular stroma for the engineering of vascularized tissues. Int J Oral Maxillofac Surg 2001;30:414-20.
121. Lovett M, Lee K, Edwards A, Kaplan DL.Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 2009;15:353-70.
122. Guyette JP, Gilpin SE, Charest JM, Tapias LF, Ren X, Ott HC. Perfusion decellularization of whole organs. Nat Protoc 2014;9: 1451-68.
123. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials 2011;32: 3233-43.
124. Azhim A, Yamagami K, Muramatsu K, Morimoto Y, Tanaka M. The use of sonication treatment to completely decellularize blood arteries: A pilot study. Conf Proc IEEE Eng Med Biol Soc 2011; 2011:2468-71.
125. Wang YN, Khokhlova TD, Maxwell AD, Kreider W, Partanen A, Farr N, et al. Tissue decellularization with boiling histotripsy and the potential in regenerative medicine. J Acoust Soc Am 2014; 136:2278.
126. Köhler MO, Mougenot C, Quesson B, Enholm J, Le Bail B, Laurent C, et al. Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys 2009;36:3521-35.
127. Lin KW, Duryea A, Kim Y, Hall T, Xu Z, Cain C. Dual-beam histotripsy: A low-frequency pump enabling a high-frequency probe for precise lesion formation. IEEE Trans Ultrason Ferroelectr Freq Control 2014;61:325-40.
128. Lin KW, Hall T, McGough R, Xu Z, Cain C. Synthesis of monopolar ultrasound pulses for therapy: The frequencycompounding transducer. IEEE Trans Ultrason Ferroelectr Freq Control 2014;61:1123-36.
129. Atchley AA. The crevice model of bubble nucleation. J Acoust Soc Am 1989;86:1065-84.
130. Harvey E, Barnes K, McElroy W, Whitely A, Pease D, Cooper K. Bubble formation in animals, II. Gas nuclei and their distribution in blood and tissues. J Cell Comp Physiol 1944;21:23-34.
131. Yount DE. Skins of varying permeability: A stabilization mechanism for gas cavitation nuclei. J Acoust Soc Am 1979;65: 1429-39.
132. Vinogradova OI, Bunkin NF, Churaev NV, Kiseleva OA, Lobeyev AV, Ninham BW. Submicrocavity structure of water between hydrophobic and hydrophilic walls as revealed by optical cavitation. J Colloid Interf Sci 1995;173:443-7.
133. Apfel RE, Holland CK. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol 1991;17:179-85.
134. Fisher JC. The fracture of liquids. J Appl Phys 1948;19:1062-7.
135. Church CC. Spontaneous homogeneous nucleation, inertial cavitation and the safety of diagnostic ultrasound. Ultrasound Med Biol 2002;28:1349-64.